Rationale for New Topical Anthroponotic Cutaneous Leishmaniasis (ACL) Treatment in Kabul
Clinical trial NCT00947362 · COMPLETED
Trial details
- NCT number
- NCT00947362
- Sponsor
- Waisenmedizin e. V. Promoting Access to Essential Medicine
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-08-01
- Primary completion
- 2007-12-15
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.